Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 13

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 13
---
four business days after the final results are known to us, file an additional Current Report on Form 8-K to publish the final results.

| 6 |

<div align='center'>INFORMATION ABOUT STOCK OWNERSHIP

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information as of April
3, 2025, with respect to the ownership of our common stock, by (i) each person known by us to be the beneficial owner of more than five
percent (5%) of the outstanding shares of each class of our capital stock, (ii) each of our directors and director nominees, (iii) each
of our executive officers, and (iv) all of our named executive officers and directors as a group. As of such date, we had 16,085,767 shares
of our common stock issued and outstanding. We believe that each individual or entity named has sole investment and voting power with
respect to shares of common stock indicated as beneficially owned by them, subject to community property laws where applicable, except
where otherwise noted. Unless otherwise indicated, the address for each person listed in the table below is c/o Aethlon Medical, Inc.,
11555 Sorrento Valley Road, Suite 203, San Diego, CA 92121.

| NAME OF BENEFICIAL OWNER                                                       |     | NUMBER OF SHARES BENEFICIALLY 
                      OWNED(1) |     | PERCENT OF SHARES BENEFICIALLY 
 OWNED(2)                       |
| Greater than 5% Stockholders                                                   |     |                               |     |                                |
| Ikarian Capital, LLC                                                           |     |                     1,229,285 |  -3 | 7.6%                           |
| Directors and Named Executive Officers                                         |     |                               |     |                                |
| James B. Frakes, Chief Executive Officer, Chief Financial Officer and Director |     |                        22,429 |  -4 | *                              |
| Edward G. Broenniman, Chairman and Director                                    |     |                        39,070 |  -5 | *                              |
| Chetan S. Shah, M.D., Director                                                 |     |                        31,375 |  -6 | *                              |
| Angela Rossetti, Director                                                      |     |                        49,660 |  -7 | *                              |
| Guy F. Cipriani, Senior Vice President, Chief Operating Officer                |     |